<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-ijms-21-05145">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eckhardt</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Cummings</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Rajagopalan</surname>
    <given-names>K.N.</given-names>
   </name>
   <name>
    <surname>Borden</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bitan</surname>
    <given-names>Z.C.</given-names>
   </name>
   <name>
    <surname>Wolf</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kantor</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Briese</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Jacobson</surname>
    <given-names>S.D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial</article-title>
  <source>Trials</source>
  <year>2020</year>
  <volume>21</volume>
  <fpage>1</fpage>
  <lpage>3</lpage>
  <pub-id pub-id-type="doi">10.1186/s13063-020-04422-y</pub-id>
  <pub-id pub-id-type="pmid">31898511</pub-id>
 </element-citation>
</ref>
